Crisaborole Ointment Effect on Global Atopic Dermatitis Severity and Early Relief in Pruritus: Pooled Results From Two Phase 3 Clinical Trials

被引：0

作者：

Paller, Amy S. ^{[1
]}

Yosipovitch, Gil ^{[2
]}

Tom, Wynnis L. ^{[3
,4
]}

Lebwohl, Mark ^{[5
]}

Boguniewicz, Mark ^{[6
,7
]}

Call, Robert S. ^{[8
]}

Eichenfield, Lawrence F. ^{[3
,4
]}

Forsha, Douglass W. ^{[9
]}

Rees, William C. ^{[10
]}

Simpson, Eric L. ^{[11
]}

Gold, Linda F. Stein ^{[12
]}

Zaenglein, Andrea L. ^{[13
]}

Tallman, Anna M. ^{[14
]}

Tan, Bill ^{[14
]}

Hebert, Adelaide A. ^{[15
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[2] Univ Miami, Miller Sch Med, Miami, FL 33136 USA

[3] Rady Childrens Hosp San Diego, San Diego, CA USA

[4] Univ Calif San Diego, San Diego, CA 92103 USA

[5] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[6] Natl Jewish Hlth, Denver, CO USA

[7] Univ Colorado, Sch Med, Denver, CO USA

[8] Clin Res Partners, Richmond, VA USA

[9] Jordan Valley Dermatol & Res Ctr, W Jordan, UT USA

[10] PI Coor Clin Res, Burke, VA USA

[11] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[12] Henry Ford Hlth Syst, Detroit, MI USA

[13] Penn State Univ, Hershey, PA USA

[14] Pfizer Inc, New York, NY USA

[15] Univ Texas Houston, Med Ctr, Houston, TX USA

来源：

PEDIATRICS | 2018年 / 142卷

关键词：

D O I：

10.1542/peds.142.1_MeetingAbstract.815

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

815

引用

页数：2

共 50 条

[31] Management of Truncal Acne With Oral Sarecycline: Pooled Results from Two Phase-3 Clinical Trials [J].

Del Rosso, James Q. ;

Gold, Linda Stein ;

Baldwin, Hilary ;

Harper, Julie C. ;

Zeichner, Joshua ;

Obagi, Sabine ;

Graber, Emmy ;

Jimenez, Xochitl ;

Vicente, Francisco Hernandez ;

Grada, Ayman .

JOURNAL OF DRUGS IN DERMATOLOGY, 2021, 20 (06) :634-640

[32] Dupilumab reduces absenteeism in patients with moderate to severe atopic dermatitis: Pooled results from the LIBERTY AD SOLO clinical trials [J].

de Bruin-Weller, Marjolein ;

Simpson, Eric L. ;

Cork, Michael ;

Chen, Zhen ;

Msihid, Jerome ;

Taniou, Christine ;

Eckert, Laurent ;

Gadkari, Abhijit ;

Bego-Le Bagousse, Gaelle .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (05) :1499-1501

[33] Dupilumab in moderate-to-severe atopic dermatitis: results from two randomized phase 3 trials (SOLO 1 & 2) [J].

Simpson, E. L. ;

Bieber, T. ;

Guttman-Yassky, E. ;

Beck, L. A. ;

Blauvelt, A. ;

Cork, M. J. ;

Silverberg, J. I. ;

Deleuran, M. ;

Kataoka, Y. ;

Lacour, J. -P. ;

Kingo, K. ;

Worm, M. ;

Poulin, Y. ;

Wollenberg, A. ;

Soo, Y. ;

Graham, N. M. H. ;

Pirozzi, G. ;

Akinlade, B. ;

Staudinger, H. ;

Mastey, V. ;

Eckert, L. ;

Gadkari, A. ;

Ardeleanu, M. .

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 :79-79

[34] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults: A pooled analysis of two phase 2 clinical trials [J].

Tofte, Susan J. ;

Papp, Kim ;

Sadick, Neil ;

Bohnert, Krista ;

Simpson, Eric ;

Thaci, Diamant ;

Bieber, Thomas ;

Blauvelt, Andrew ;

Sofen, Howard ;

Gooderham, Melinda ;

Chen, Zhen ;

Gadkari, Abhijit ;

Eckert, Laurent ;

Graham, Neil M. H. ;

Pirozzi, Gianluca ;

Ardeleanu, Marius .

JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2018, 30 (09) :529-541

[35] Two phase 3 study results of children and adults with mild-to-moderate atopic dermatitis treated with Crisaborole Topical Ointment, 2%, a novel, nonsteroidal, topical, anti-inflammatory, phosphodiesterase 4 inhibitor [J].

Zane, Lee Thomas ;

Paller, Amy S. ;

Tom, Wynnis L. ;

Lebwohl, Mark G. ;

Blumenthal, Robin L. ;

Boguniewicz, Mark ;

Call, Robert S. ;

Eichenfield, Lawrence F. ;

Forsha, Douglass W. ;

Rees, William C. ;

Simpson, Eric L. ;

Gold, Linda F. Stein ;

Zaenglein, Andrea L. ;

Hebert, Adelaide A. .

JOURNAL OF IMMUNOLOGY, 2016, 196

[36] Effect of Dupilumab on Global Individual Signs Score Outcomes in Adults With Moderate-to-Severe Atopic Dermatitis: Combined Results From Four Phase 3 Trials [J].

Staubach-Renz, P. ;

Silverberg, J. ;

de Bruin-Weller, M. ;

Irvine, A. D. ;

Ardeleanu, M. ;

Chen, Z. ;

Clibborn, C. ;

Sorrentino, A. ;

Rossi, A. B. .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) :S244-S244

[37] Efficacy of ruxolitinib cream among patients with atopic dermatitis based on previous medication history: Pooled results from two phase 3 studies [J].

Blauvelt, Andrew ;

Eichenfield, Lawrence F. ;

Kuligowski, Michael E. ;

Venturanza, May E. ;

Sun, Kang ;

Silverberg, Jonathan I. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) :AB148-AB148

[38] A novel, nonsteroidal, topical, anti-inflammatory, phosphodiesterase inhibitor, Crisaborole Topical Ointment, 2%, in two phase 3 studies in children and adults with mild to moderate atopic dermatitis [J].

Paller, A. S. ;

Tom, W. L. ;

Call, R. S. ;

Eichenfield, L. ;

Forsha, D. ;

Rees, W. ;

Spellman, M. ;

Zane, L. T. ;

Hebert, A. A. .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (09) :S166-S166

[39] Effect of BMI on Baricitinib Efficacy: Pooled Analysis from Two Phase 3 Rheumatoid Arthritis Clinical Trials [J].

Zerbini, Cristiano A. F. ;

Muram, David ;

Arora, Vipin K. ;

Alam, Jahangir ;

Curtis, Jeffrey R. .

ARTHRITIS & RHEUMATOLOGY, 2016, 68

[40] Peak Pruritus Numeric Rating Scale response with abrocitinib in patients with moderate to severe atopic dermatitis: Results from a randomized phase 3 clinical trial [J].

Simpson, Eric L. ;

Staender, Sonja ;

Yosipovitch, Gil ;

Cameron, Michael C. ;

DiBonaventura, Marco ;

Williams, David ;

Tatulych, Svitlana ;

Nduaka, Chudy ;

Valdez, Hernan .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) :AB61-AB61

← 1 2 3 4 5 →